Literature DB >> 1385928

Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation.

T R Ulich1, K Guo, S Yin, J del Castillo, E S Yi, R C Thompson, S P Eisenberg.   

Abstract

After the intravenous (IV) injection of endotoxin, (lipopolysaccharide [LPS]), in the rat, interleukin-1 alpha/beta (IL-1 alpha/beta) mRNA expression peaks at 1 hour in whole organ RNA preparations of the lung, liver, spleen, and bowel. Interleukin-1 receptor antagonist (IL-1ra) mRNA peaks at 2 to 4 hours, consistent with the hypothesis that IL-1ra acts as an endogenous negative feedback mechanism to downregulate the proinflammatory effects of IL-1. After the intratracheal (IT) injection of LPS, however, IL-1 and IL-1ra mRNA levels in whole lung peak at 6 hours, concurrent with the maximum influx of neutrophils (PMNs) into the bronchoalveolar space. To address the cellular source of IL-1 and IL-1ra mRNA in the lung during acute pneumonitis, mRNA levels were studied in bronchoalveolar lavage (BAL) macrophages incubated with LPS in vitro for 6 hours as compared with BAL cells (95% PMNs) obtained 6 hours after IT injection of LPS. A much greater expression of IL-1 and IL-1ra mRNA was observed in PMN-rich BAL cells obtained after IT injection of LPS, suggesting that PMNs contribute substantially to IL-1 and IL-1ra mRNA expression. Fractionation of alveolar macrophage-enriched and PMN-enriched subpopulations from the BAL cells obtained at 6 hours after IT injection of LPS confirmed that neutrophils are a source of IL-1 and IL-1ra mRNA. The difference in the kinetics of IL-1 and IL-1ra mRNA expression in whole lung RNA preparations after IV and IT injections of LPS is due to the contribution of PMNs that appear in the lung in large numbers after IT injection. Finally, human peripheral blood PMNs were found to express IL-1ra mRNA and protein after in vitro incubation with LPS. PMNs may contribute to the up- and downregulation of their own accumulation by expressing both IL-1 and IL-1ra.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385928      PMCID: PMC1886562     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  17 in total

1.  Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6.

Authors:  T R Ulich; K Z Guo; D Remick; J del Castillo; S M Yin
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

2.  cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium.

Authors:  S Haskill; G Martin; L Van Le; J Morris; A Peace; C F Bigler; G J Jaffe; C Hammerberg; S A Sporn; S Fong
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

3.  Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor.

Authors:  C H Hannum; C J Wilcox; W P Arend; F G Joslin; D J Dripps; P L Heimdal; L G Armes; A Sommer; S P Eisenberg; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

Review 4.  Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in gram-negative infection.

Authors:  M I Cybulsky; M K Chan; H Z Movat
Journal:  Lab Invest       Date:  1988-04       Impact factor: 5.662

5.  Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression.

Authors:  T R Ulich; K Z Guo; B Irwin; D G Remick; G N Davatelis
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

6.  Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.

Authors:  W P Arend; H G Welgus; R C Thompson; S P Eisenberg
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

7.  Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist.

Authors:  S P Eisenberg; R J Evans; W P Arend; E Verderber; M T Brewer; C H Hannum; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

8.  Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.

Authors:  K Ohlsson; P Björk; M Bergenfeldt; R Hageman; R C Thompson
Journal:  Nature       Date:  1990-12-06       Impact factor: 49.962

9.  Inducible interleukin-1 gene expression in human vascular smooth muscle cells.

Authors:  P Libby; J M Ordovas; L K Birinyi; K R Auger; C A Dinarello
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

10.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

View more
  17 in total

1.  Mediators of ischemia-reperfusion injury of rat lung.

Authors:  M J Eppinger; G M Deeb; S F Bolling; P A Ward
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia.

Authors:  M Schafer; S A Mousa; Q Zhang; L Carter; C Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1.

Authors:  T K Held; X Weihua; L Yuan; D V Kalvakolanu; A S Cross
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome.

Authors:  Xianbao He; Samrawit Mekasha; Nikolaos Mavrogiorgos; Katherine A Fitzgerald; Egil Lien; Robin R Ingalls
Journal:  J Immunol       Date:  2010-04-14       Impact factor: 5.422

5.  BPIFA1 regulates lung neutrophil recruitment and interferon signaling during acute inflammation.

Authors:  Clemente J Britto; Naiqian Niu; Sara Khanal; Luai Huleihel; Jose D Herazo-Maya; Alison Thompson; Maor Sauler; Martin D Slade; Lokesh Sharma; Charles S Dela Cruz; Naftali Kaminski; Lauren E Cohn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-21       Impact factor: 5.464

6.  Lipopolysaccharide induced apoptosis of rat pancreatic acinar cells.

Authors:  V J Laine; K M Nyman; H J Peuravuori; K Henriksen; M Parvinen; T J Nevalainen
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

7.  Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.

Authors:  F W Tam; J Smith; S J Cashman; Y Wang; E M Thompson; A J Rees
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

8.  Streptococcal cysteine protease augments lung injury induced by products of group A streptococci.

Authors:  T P Shanley; D Schrier; V Kapur; M Kehoe; J M Musser; P A Ward
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin.

Authors:  M M Campos; G E Souza; J B Calixto
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

10.  Polymorphonuclear leukocytes as a significant source of tumor necrosis factor-alpha in endotoxin-challenged lung tissue.

Authors:  Z Xing; H Kirpalani; D Torry; M Jordana; J Gauldie
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.